Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer-Reference-Cited by-同舟云学术

Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer

Published:2022-05 Issue: Volume:149 Page:112844
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

López-Camacho Elena,Trilla-Fuertes Lucía,Gámez-Pozo Angelo,Dapía Irene,López-Vacas Rocío,Zapater-Moros Andrea,Lumbreras-Herrera María Isabel,Arias Pedro,Zamora Pilar,Vara Juan Ángel Fresno,Espinosa Enrique

Funder

Government of Spain Ministry of Economy and Competitiveness

Roche

Ministerio de Economía y Competitividad

Consejeria de Educacion e Investigacion

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference61 articles.

1. Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection;Lehmann;PLoS One,2016

2. Breast cancer treatments: updates and new challenges;Burguin;J. Pers. Med,2021

3. SEOM clinical guidelines in early stage breast cancer (2018);Ayala de la Peña;Clin. Transl. Oncol.,2019

4. Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here;Kwa;Cancer,2018

5. Pembrolizumab for early triple-negative breast cancer;Schmid;N. Engl. J. Med,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ETS1 drives EGF-induced glycolytic shift and metastasis of epithelial ovarian cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Metabolic vulnerabilities in cancer: A new therapeutic strategy;Critical Reviews in Oncology/Hematology;2024-09

3. Reduction-Responsive Polyprodrug Nanoplatform Based on Curcumin for Tumor-Targeted Therapy;Current Drug Delivery;2024-07-24

4. Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release;Journal of Translational Medicine;2024-07-01

5. An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer;Molecules;2023-08-01